Solbec Pharmaceuticals Limited has announced its lead anti-cancer compound Coramsine has received orphan drug designation from the US Food and Drug Administration.

Solbec Pharmaceuticals Limited has announced its lead anti-cancer compound Coramsine has received orphan drug designation from the US Food and Drug Administration.